Xywav

Xywav, bụ ọgwụ a na-eji agwọ cataplexy ma ọ bụ ụra ehihie gabigara ókè (EDS).^[1] O nwere nzube magburu onwe ha na kpo ngwakọta nke nnu oxybate, ya bụ Calcium oxybate. A na-aṅụ ya n'ọnụ.

N'ịbụ nke ụlọ ọrụ Jazz Pharmaceuticals mepụtara site na iji bịa na ímé ihe, a kwadoro ya maka iji ya mee ihe na United States na July 2020.^[2]^[3]

Ojiji ọgwụ[dezie | dezie ebe o si]

A na-egosi Xywav maka ọgwụgwọ nke cataplexy nke ụwa họrọ site na iji bịa na na ndị dị afọ asaa ma ọ bụ karịa na narcolepsy.

N'ọnwa Ọgọstụ 2021, U.S. Food and Drug Administration (FDA) kwadoro Xywav maka ọgwụgwọ nke idiopathic hypersomnia.

Mmetụta Ndị Ọzọ[dezie | dezie ebe o si]

Nsogbu iku ume[dezie | dezie ebe o si]

Ịdị nwayọ iku ume, Nsogbu iku ume, apnea ụra^[4]

Nsogbu Ahụ Ike Uche[dezie | dezie ebe o si]

Mgbagwoju anya, Hallucination, echiche ndị a na-adịghị ahụkebe ma ọ bụ ndị na-enye nsogbu (echiche na-adịghị mma), nchegbu, ịda mbà n'obi, echiche ma ọ bụ omume igbu onwe onye, ike ọgwụgwụ na-arịwanye elu, mmetụta nke obi amamikpe ma ọ bụ enweghị uru, Ihe isi ike ilekwasị anya^[4]

Ndị ọzọ[dezie | dezie ebe o si]

Ọha na omenala[dezie | dezie ebe o si]

Ọnọdụ iwu[dezie | dezie ebe o si]

U.S. Food and Drug Administration (FDA) nyere Xywav aha ọgwụ na-enweghị nne na nna na Nọvemba 1994.^[5] FDA nyere nkwado nke Xywav na Jazz Pharmaceuticals plc n'ọnwa Ọgọstụ 2021.^[6]

Aha ndị ọzọ[dezie | dezie ebe o si]

Ntụaka[dezie | dezie ebe o si]

↑ (13 November 2021) "Sleep-Wake Medications", Varcarolis' Manual of Psychiatric Nursing Care. Elsevier Health Sciences. ISBN 978-0-323-79306-3.
↑ Drug Approval Package: Xywav. U.S. Food and Drug Administration (FDA) (7 May 2021). Retrieved on 12 August 2021.
↑ Drug Approval Package: Xywav. U.S. Food and Drug Administration (FDA) (7 May 2021). Retrieved on 19 November 2021.
↑ ^4.0 ^4.1 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212690s000lbl.pdf
↑ Xywav Orphan Drug Designations and Approvals. U.S. Food and Drug Administration (FDA). Retrieved on 12 August 2021.
↑ Kpọpụta njehie: Invalid <ref> tag; no text was provided for refs named FDA PR 20210812

[1] (13 November 2021) "Sleep-Wake Medications", Varcarolis' Manual of Psychiatric Nursing Care. Elsevier Health Sciences. ISBN 978-0-323-79306-3.

[2] Drug Approval Package: Xywav. U.S. Food and Drug Administration (FDA) (7 May 2021). Retrieved on 12 August 2021.

[3] Drug Approval Package: Xywav. U.S. Food and Drug Administration (FDA) (7 May 2021). Retrieved on 19 November 2021.

[:03-4] 4.0 ^4.1 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212690s000lbl.pdf

[5] Xywav Orphan Drug Designations and Approvals. U.S. Food and Drug Administration (FDA). Retrieved on 12 August 2021.

[FDA_PR_20210812-6] Kpọpụta njehie: Invalid <ref> tag; no text was provided for refs named FDA PR 20210812

[1]

[2]

[3]

[4]

[5]

[6]